Global

Medical Sciences Experts

Cindy B. Matsen

Professor
Department of Surgery
Huntsman Cancer Institute
United States of America

Biography

Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Assistant Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitiation and how better training of providers in preference elcitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

Research Interest

Surgery Breast Cancer Breast Surgery Breast Disease

Publications

  • Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS 3rd (2016). Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile? Ann Surg Oncol, 23(3), 744-8.

  • Kaphingst KA, Ivanovich J, Elrick A, Dresser R, Matsen C, Goodman MS (2016). How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age. Mol Genet Genomic Med, 4(6), 684-695.

  • Cohen AL, Factor RE, Mooney K, Salama ME, Wade M, Serpico V, Ostrander E, Nelson E, Porretta J, Matsen C, Bernard P, Boucher K, Neumayer L (2017). POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen. Breast, 31, 219-223.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America